Over 60 companies are developing GLP-1 drugs
Poster sessions held throughout the day gave trainees the opportunity to present their work and receive feedback from faculty and peers
35 SGLT-1 is primarily responsible for glucose absorption in the gastrointestinal tract and only accounts for approximately 10% of glucose reabsorption in the kidney
The blend is disclosed by weight, at 36 mg total, with no CFU (colony-forming unit) count and no live-versus-pasteurized status stated for Akkermansia muciniphila specifically - a detail that matters, since the human research on this strain (a randomized trial in Nature Medicine ) used a pasteurized form dosed by cell count, not by weight
Moss CE, Marsh WJ, Parker HE, Ogunnowo-Bada E, Riches CH, Habib AM, et al